The Unified European Registry for Inherited Metabolic Disorders (UIMD) aims to promote health for children, adolescents and adults affected by rare Inherited Metabolic Disorders (IMDs).
The project has three major activities:
- Establishing the U-IMD patient registry as a tool of the European Reference Network for Hereditary Metabolic Disorders (MetabERN).
U-IMD will fully implement the common data elements of the European Platform on Rare Disease Registration (EU RD Platform) and will be integrated into the European Rare Disease Registry Infrastructure (ERDRI). U-IMD will be the first unified European registry that encompasses all IMDs.
- Upgrading already existing IMD registries to the standard of U-IMD, starting with the registry of the International Working Group on Neurotransmitter Related Disorders (iNTD).
- Developing a standard for minimal core data sets shared by the MetabERN and the European Rare Kidney Disease Reference Network (ERKNet).
The U-IMD registry will cover all MetabERN IMD subgroups. U-IMD is intended to be used by physicians treating patients with rare inherited metabolic disorders. U-IMD is the official registry of MetabERN but is in principle open to all European and international health care providers, treating patients with IMDs.
Visit the U-IMD registry website here for more information.
Read the publication on the U-IMD here.